Quarterly report pursuant to Section 13 or 15(d)

Overview - Schedule of Restatement of Previously Issued Consolidated Financial Statements (Details)

v3.20.4
Overview - Schedule of Restatement of Previously Issued Consolidated Financial Statements (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Dec. 31, 2019
Jul. 15, 2019
Cash and cash equivalents     $ 13,370 $ 2,321  
Accounts receivable, net of allowance for doubtful accounts     9,799 10,338  
Other current assets     4,976 3,851  
Total current assets     28,145 16,510  
Property and equipment, net     6,610 6,814  
Other intangible assets, net     14,734 15,849  
Goodwill     8,433 8,433 $ 8,300
Operating lease right of use assets     2,811    
Other long-term assets     42 42  
Total assets     60,775 51,540  
Accounts payable     4,456 4,709  
Accrued salary and bonus     1,865 2,341  
Other accrued expenses     8,639 9,476  
Current liabilities from discontinued operations     766 766  
Total current liabilities     15,726 17,292  
Contingent consideration     2,264 2,391  
Operating lease liabilities, net of current portion     1,384 2,591  
Line of credit     1,200 3,000  
Other long-term liabilities     4,563 4,573  
Total liabilities     25,137 29,847  
Commitments and contingencies (Note 8)      
Preferred stock value      
Common stock value     402 393  
Additional paid-in capital     182,580 182,514  
Accumulated deficit     (192,159) (185,665)  
Treasury stock, at cost (11,781 shares)     (1,721) (1,721)  
Total stockholders' equity $ (10,898) $ 32,938 (10,898) (4,479)  
Total liabilities and stockholders' equity     14,239 25,368  
Total liabilities, preferred stock and stockholders' equity     60,775 51,540  
Revenue, net 9,059 6,010      
Cost of revenue 6,113 2,622      
Gross profit 2,946 3,388      
Sales and marketing 2,481 2,411      
Research and development 809 528      
General and administrative 4,893 2,735      
Acquisition related amortization expense 1,115 897      
Total operating expenses 9,298 6,571      
Operating loss (6,352) (3,183)      
Interest accretion (109) (129)      
Other income (expense), net 47 48      
Loss from continuing operations before tax (6,414) (3,264)      
Provision for income taxes 15 5      
Loss from continuing operations, net of tax (6,429) (3,269)      
Loss from discontinued operations, net of tax (65) (57)      
Less adjustment for preferred stock deemed dividend (3,033)      
Net loss attributable to common stockholders $ (9,527) $ (3,326)      
From continuing operations $ (2.37) $ (0.93)      
From discontinued operations (0.01) (0.01)      
Net loss per basic and diluted share of common stock $ (2.38) $ (0.94)      
Basic 4,004,000 3,515,000      
Diluted 4,004,000 3,515,000      
Balance $ (4,479) $ 32,938      
Common stock issued 1 1      
Restricted stock issued      
Common stock issued through market sales 484      
Common stock issued through offerings 5,962      
Treasury stock purchased (32)      
Extinguishment of Series A Shares (828)      
Beneficial Conversion Feature in connection with Series B Issuance 2,205      
Amortization of Beneficial Conversion Feature (2,205)      
Stock-based compensation expense 418 266      
Adoption of ASC 842 55      
Net loss (6,494) (3,326)      
Balance (10,898) 18,372      
Depreciation and amortization 1,319 957      
Interest accretion 109 129      
Mark to market on warrants (26) (3)      
Stock-based compensation 418 538      
Bad debt expense 250      
Other gains and expenses, net 18      
Decrease (increase) in accounts receivable 289 (1,738)      
(Increase) decrease in other current assets (1,125) 11      
(Decrease) increase in accounts payable (253) 93      
(Decrease) increase in accrued salaries and bonus (476) 205      
(Decrease) increase in accrued liabilities (1,149) 99      
Increase in long-term liabilities 16 57      
Net cash used in operating activities (7,122) (2,960)      
Purchase of property and equipment (12)      
Sale of property and equipment 13      
Net cash provided by investing activity 1      
Issuance of common stock, net of expenses 434 6,015      
Payments on Line of Credit (1,800)      
Issuance of Series B preferred stock, net of expenses 19,537      
Net cash provided by financing activities 18,171 6,015      
Net increase in cash and cash equivalents 11,049 3,056      
Cash and cash equivalents - beginning 2,321 6,068      
Cash and cash equivalents - ending 13,370 9,124      
Common Stock [Member]          
Total stockholders' equity 402 382 402 393  
Balance $ 393 $ 287      
Balance, shares 3,932,000 2,877,000      
Common stock issued $ 1 $ 1      
Common stock issued, shares 37,000 9,000      
Restricted stock issued      
Restricted stock issued, shares 6,000      
Common stock issued through market sales $ 8      
Common stock issued through market sales, shares 80,000      
Common stock issued through offerings $ 94      
Common stock issued through offerings, shares 933,000      
Treasury stock purchased      
Treasury stock purchased, shares      
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense      
Adoption of ASC 842      
Net loss      
Balance $ 402 $ 382      
Balance, shares 4,055,000 3,819,000      
Treasury Stock [Member]          
Total stockholders' equity $ (1,721) $ (1,712) (1,721) (1,721)  
Balance $ (1,721) $ (1,680)      
Balance, shares 12,000 7,000      
Common stock issued      
Common stock issued, shares      
Restricted stock issued      
Restricted stock issued, shares      
Common stock issued through market sales      
Common stock issued through market sales, shares      
Common stock issued through offerings      
Common stock issued through offerings, shares      
Treasury stock purchased $ (32)      
Treasury stock purchased, shares 3,000      
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense      
Adoption of ASC 842      
Net loss      
Balance $ (1,721) $ (1,712)      
Balance, shares 12,000 10,000      
Additional Paid-in Capital [Member]          
Total stockholders' equity $ 182,580 $ 181,954 182,580 182,514  
Balance 182,514 175,820      
Common stock issued      
Restricted stock issued      
Common stock issued through market sales 476      
Common stock issued through offerings 5,868      
Treasury stock purchased      
Extinguishment of Series A Shares (828)      
Beneficial Conversion Feature in connection with Series B Issuance 2,205      
Amortization of Beneficial Conversion Feature (2,205)      
Stock-based compensation expense 418 266      
Adoption of ASC 842      
Net loss      
Balance 182,580 181,954      
Accumulated Deficit [Member]          
Total stockholders' equity (192,159) (162,252) (192,159) (185,665)  
Balance (185,665) (158,981)      
Common stock issued      
Restricted stock issued      
Common stock issued through market sales      
Common stock issued through offerings      
Treasury stock purchased      
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense      
Adoption of ASC 842 55      
Net loss (6,494) (3,326)      
Balance (192,159) (162,252)      
As Previously Reported [Member]          
Cash and cash equivalents     13,370    
Accounts receivable, net of allowance for doubtful accounts     9,799    
Other current assets     4,976    
Total current assets     28,145    
Property and equipment, net     6,610    
Other intangible assets, net     32,470    
Goodwill     8,433    
Operating lease right of use assets     2,811    
Other long-term assets     42    
Total assets     78,511    
Accounts payable     4,456    
Accrued salary and bonus     1,865    
Other accrued expenses     8,639    
Current liabilities from discontinued operations     766    
Total current liabilities     15,726    
Contingent consideration     2,264    
Operating lease liabilities, net of current portion     1,384    
Line of credit     1,200    
Other long-term liabilities     4,563    
Total liabilities     25,137    
Commitments and contingencies (Note 8)        
Preferred stock value     46,536    
Common stock value     402    
Additional paid-in capital     182,580    
Accumulated deficit     (174,423)    
Treasury stock, at cost (11,781 shares)     (1,721)    
Total stockholders' equity 6,838 35,771 6,838    
Total liabilities and stockholders' equity     31,975    
Total liabilities, preferred stock and stockholders' equity     78,511    
Revenue, net 9,200 6,010      
Cost of revenue 6,113 2,622      
Gross profit 3,087 3,388      
Sales and marketing 2,481 2,411      
Research and development 809 528      
General and administrative 4,887 2,912      
Acquisition related amortization expense 1,031 813      
Total operating expenses 9,208 6,664      
Operating loss (6,121) (3,276)      
Interest accretion (109) (129)      
Other income (expense), net 47 48      
Loss from continuing operations before tax (6,183) (3,357)      
Provision for income taxes 15 5      
Loss from continuing operations, net of tax (6,198) (3,362)      
Loss from discontinued operations, net of tax (65) (57)      
Less adjustment for preferred stock deemed dividend (3,033)      
Net loss attributable to common stockholders $ (9,296) $ (3,419)      
From continuing operations $ (2.31) $ (0.96)      
From discontinued operations (0.01) (0.01)      
Net loss per basic and diluted share of common stock $ (2.32) $ (0.97)      
Basic 4,004,000 3,515,000      
Diluted 4,004,000 3,515,000      
Net loss $ (6,263) $ (3,419)      
Balance 6,838 35,771      
Depreciation and amortization 1,235 873      
Interest accretion 109 129      
Mark to market on warrants (26) (3)      
Stock-based compensation 418 538      
Bad debt expense 250      
Other gains and expenses, net 18      
Decrease (increase) in accounts receivable 148 (1,738)      
(Increase) decrease in other current assets (1,125) 11      
(Decrease) increase in accounts payable (356) 93      
(Decrease) increase in accrued salaries and bonus (476) 325      
(Decrease) increase in accrued liabilities (1,052) 156      
Increase in long-term liabilities 16 57      
Net cash used in operating activities (7,122) (2,960)      
Purchase of property and equipment (12)      
Sale of property and equipment 13      
Net cash provided by investing activity 1      
Issuance of common stock, net of expenses 434 6,015      
Payments on Line of Credit (1,800)        
Issuance of Series B preferred stock, net of expenses 19,537        
Net cash provided by financing activities 18,171 6,015      
Net increase in cash and cash equivalents 11,049 3,056      
Cash and cash equivalents - beginning 2,321 6,068      
Cash and cash equivalents - ending 13,370 9,124      
As Previously Reported [Member] | Common Stock [Member]          
Total stockholders' equity 402 287 402 393  
Balance $ 393 $ 287      
Balance, shares 3,932,000 2,877,000      
Common stock issued $ 1 $ 1      
Common stock issued, shares 37,000 9,000      
Restricted stock issued      
Restricted stock issued, shares 6,000      
Common stock issued through market sales $ 8      
Common stock issued through market sales, shares 80,000      
Common stock issued through offerings $ 94      
Common stock issued through offerings, shares 933,000      
Balance $ 402 $ 382      
Balance, shares 4,055,000 3,819,000      
As Previously Reported [Member] | Treasury Stock [Member]          
Total stockholders' equity $ (1,721) $ (1,680) (1,721) (1,721)  
Balance $ (1,721) $ (1,680)      
Balance, shares 12,000 7,000      
Treasury stock purchased $ (32)      
Treasury stock purchased, shares 3,000      
Balance $ (1,721) $ (1,712)      
Balance, shares 12,000 10,000      
As Previously Reported [Member] | Additional Paid-in Capital [Member]          
Total stockholders' equity $ 182,514 $ 181,954 182,580 182,514  
Balance 182,514 175,820      
Common stock issued through market sales 476      
Common stock issued through offerings 5,868      
Extinguishment of Series A Shares (828)      
Beneficial Conversion Feature in connection with Series B Issuance 2,205      
Amortization of Beneficial Conversion Feature (2,205)      
Stock-based compensation expense 418 266      
Balance 182,580 181,954      
As Previously Reported [Member] | Accumulated Deficit [Member]          
Total stockholders' equity (174,423) (144,853) (174,423) (168,160)  
Balance (168,160) (141,489)      
Adoption of ASC 842 55      
Net loss (6,263) (3,419)      
Balance (174,423) (144,853)      
Restatement Amount [Member]          
Cash and cash equivalents        
Accounts receivable, net of allowance for doubtful accounts        
Other current assets        
Total current assets        
Other intangible assets, net     (17,736)    
Goodwill        
Operating lease right of use assets        
Other long-term assets        
Total assets     (17,736)    
Accounts payable        
Accrued salary and bonus        
Other accrued expenses        
Current liabilities from discontinued operations        
Total current liabilities        
Contingent consideration        
Operating lease liabilities, net of current portion        
Line of credit        
Other long-term liabilities        
Total liabilities        
Commitments and contingencies (Note 8)        
Preferred stock value        
Common stock value        
Additional paid-in capital        
Accumulated deficit     (17,736)    
Treasury stock, at cost (11,781 shares)        
Total stockholders' equity (17,736) (17,399) (17,736)    
Total liabilities and stockholders' equity     (17,736)    
Total liabilities, preferred stock and stockholders' equity     (17,736)    
Revenue, net (141)      
Cost of revenue      
Gross profit (141)      
Sales and marketing      
Research and development      
General and administrative 6 (177)      
Acquisition related amortization expense 84 84      
Total operating expenses 90 (93)      
Operating loss (231) 93      
Interest accretion      
Other income (expense), net      
Loss from continuing operations before tax (231) 93      
Provision for income taxes      
Loss from continuing operations, net of tax (231) 93      
Loss from discontinued operations, net of tax      
Less adjustment for preferred stock deemed dividend      
Net loss attributable to common stockholders $ (231) $ 93      
From continuing operations $ (0.06) $ 0.03      
Net loss per basic and diluted share of common stock $ (0.06) $ 0.03      
Basic 4,004,000 3,515,000      
Diluted 4,004,000 3,515,000      
Net loss $ (231) $ 93      
Balance (17,736) (17,399)      
Depreciation and amortization 84 84      
Interest accretion      
Mark to market on warrants      
Stock-based compensation      
Bad debt expense      
Other gains and expenses, net      
Decrease (increase) in accounts receivable 141      
(Increase) decrease in other current assets      
(Decrease) increase in accounts payable 103      
(Decrease) increase in accrued salaries and bonus (120)      
(Decrease) increase in accrued liabilities (97) (57)      
Increase in long-term liabilities      
Net cash used in operating activities      
Purchase of property and equipment      
Sale of property and equipment      
Net cash provided by investing activity      
Issuance of common stock, net of expenses      
Payments on Line of Credit        
Issuance of Series B preferred stock, net of expenses        
Net cash provided by financing activities      
Net increase in cash and cash equivalents      
Cash and cash equivalents - beginning      
Cash and cash equivalents - ending      
Restatement Amount [Member] | Common Stock [Member]          
Total stockholders' equity    
Balance      
Common stock issued      
Restricted stock issued        
Restricted stock issued, shares        
Common stock issued through market sales        
Common stock issued through offerings        
Balance        
Restatement Amount [Member] | Treasury Stock [Member]          
Total stockholders' equity  
Balance      
Balance, shares        
Treasury stock purchased      
Balance      
Balance, shares        
Restatement Amount [Member] | Additional Paid-in Capital [Member]          
Total stockholders' equity  
Balance      
Common stock issued through market sales        
Common stock issued through offerings        
Extinguishment of Series A Shares        
Beneficial Conversion Feature in connection with Series B Issuance        
Amortization of Beneficial Conversion Feature        
Stock-based compensation expense        
Balance      
Restatement Amount [Member] | Accumulated Deficit [Member]          
Total stockholders' equity (17,505) (17,492) $ (17,736) $ (17,505)  
Balance (17,505) (17,492)      
Adoption of ASC 842      
Net loss (231) 93      
Balance $ (17,736) $ (17,399)